EDS Accelerator Award
EDS Accelerator Award supports independent cancer researchers with technology development, validation, and de-risking funding to advance the commercialization of ongoing cancer research projects.
This grant is no longer accepting proposals
American Cancer Society has archived this opportunity.
Funder: American Cancer Society
Due Dates: Rolling (application due within 60 days of creation in ProposalCentral)
Funding Amounts: $75,000 in direct costs for one year; indirect costs are not allowed
Summary: Supports commercialization of ongoing cancer research through technology validation and de-risking.
Key Information: Independent investigators at any career stage may apply through eligible nonprofit institutions in the US and its territories.
Description
The EDS Accelerator Award supports independent investigators pursuing commercialization of an ongoing cancer research project. Its focus is technology development: validating technologies and reducing technological risk to advance the project's commercialization goals. The award is open to investigators at any career stage and provides a one-year period of support for these activities.
The American Cancer Society administers the award through its Extramural Discovery Science (EDS) team, which manages the grant process. ACS supports basic, translational, clinical, and cancer control research as financial resources permit. This opportunity specifically addresses commercialization and technology validation within research already underway. Applications are submitted and reviewed through ProposalCentral.
